Connect with execs from Axios, The New York Times, Paramount and more.
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
SharkNinja’s new growth strategy runs through comedy creators
Why SharkNinja is chasing new buyers with comedy instead of a celebrity pitch.
What Ally Bank learned from building a sports marketing strategy before the market caught up
Ally CMO Andrea Brimmer reveals what she’d change about the bank’s sports marketing strategy,and where sponsorships are headed.
NASCAR rebuilds its commercial engine to tempt back motorsports fans
Behind the scenes, the motorsport and racetrack business hopes a commercial refit and consumer-facing hero campaign can help it hold the line amid F1’s growing U.S. popularity.